Skip to main content

Clinical Medicine Research (UoA1)

Clinical Medicine Research (UoA1)

Who we are

We conduct most of our clinical medical research in the following University institutes:

High impact research

We organise our high quality research across five major research areas. The two types of research unit our research areas fall into are themes and Newcastle University Centres of Research Excellence (NUCoREs).

Our Cancer and Rare Disease research is broad and we lead the NUCoREs for these areas, bring together research across the faculties. They include:

Each research area includes postgraduate researchers and staff at all career stages.

A world-leading centre

We recruit and develop staff at all levels to increase our research power.

Our submission includes 168 staff, which includes 66 clinical academics and 25 early career researchers. We have a diverse personnel (36% are women, 12% Black, Asian & Minority Ethnic), and two colleagues declaring a disability. 

We also host a further 66 NHS-employed active researchers with honorary University status.

Research leadership

We lead many national and international investments, a small selection of which are:

Impact case studies

We showcase our high impact research in many case studies:

  • Approval of eculizumab and establishment of a national service to treat patients with Atypical Haemolytic Uraemic Syndrome
  • Endocuff Vision: a simple tool to increase early detection of colorectal cancer and pre-cancer
  • Remission of type 2 diabetes using a low calorie diet
  • Ataluren: the first approved oral treatment for Duchenne muscular dystrophy
  • Rucaparib targeted therapy for a range of cancers caused by homologous repair deficiency
  • Aspirin to decrease the risk of colorectal cancer for patients with Lynch syndrome
  • Treatment stratification for childhood medulloblastoma patients
  • Human-derived limbal cell transplant to treat chemical burns of the eye

Our facilities

Our facilities and infrastructure support our academic programmes. They enable partnerships with collaborators in industry and healthcare. Our investments include The Catalyst Building and The Wolfson Childhood Cancer Centre. We also have The Campus for Ageing and Vitality and new Sports and Exercise research facilities.

Our infrastructure involves Innovation Hubs which combine equipment, facilities and world-leading expertise. The Analytics Hub hosts the MRC-funded Single Cell Functional Genomics Unit.

Across the city, we co-manage four Clinical Research Facilities:

Inclusive research

Our values and practices create a research environment in which all colleagues have the opportunity to succeed.

The University is a Global Stonewall Diversity Champion. It is also a member of both the Advance HE’s Race Equality Charter and the Business Disability Forum.

In 2018, we achieved an Athena Swan Silver Faculty Award. We also focus on the challenges for clinical academics. We support them in balancing NHS, research and personal commitments.

50% of Academic Clinical Fellows and 40% of Academic Clinical Lecturers are women. The latter statistic is higher than the national average. We ensure flexible clinical training for part-time trainees. We are proud that four of our five academics elected FMedSci since 2014 are women.

One third of our doctoral students come from BAME backgrounds. To address selection bias, our largest doctoral training programmes pioneered a new system. It redacts all identifiers during both project selection and student short-listing.

Early Career Researchers

We operate a successful Early Career Researcher development programme. We receive direct support from fellowship schemes to help identify talented researchers. Since 2014 we have enabled 24 ECRs to transition to independence.

Our postgraduate research student community contributes to our research environment.